FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 20 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $51,000 | -42.7% | 25,932 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $89,000 | -57.8% | 25,932 | 0.0% | 0.00% | -75.0% |
| Q2 2021 | $211,000 | -33.9% | 25,932 | 0.0% | 0.00% | -42.9% |
| Q1 2021 | $319,000 | -32.7% | 25,932 | 0.0% | 0.01% | -46.2% |
| Q4 2020 | $474,000 | -85.3% | 25,932 | -87.4% | 0.01% | -87.7% |
| Q3 2020 | $3,222,000 | – | 206,413 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,507 | $6,217,990 | 9.26% |